Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique

R A Pierce, E D Field, J M den Haan, J A Caldwell, F M White, J A Marto, W Wang, L M Frost, E Blokland, C Reinhardus, J Shabanowitz, D F Hunt, E Goulmy, V H Engelhard

Research output: Contribution to journalArticleAcademicpeer-review


In this report, we describe the use of novel mass spectrometry instrumentation to identify a male-specific minor histocompatibility Ag restricted by HLA-A*0101 (A1-HY). This Ag has the sequence IVDC*LTEMY, where C* represents a cysteine disulfide bonded to a second cysteine residue. The core peptide sequence is found in the protein product of DFFRY, a Y chromosome gene not previously identified as the source of an HY Ag. The male-specific form of the peptide differs from its X chromosomal counterpart by the substitution of serine for the C* residue. Both peptides are expressed on the cell surface at 30 or fewer copies per cell. However, A1-HY-specific CTL recognize the DFFRY-derived peptide at a 1500-fold lower dose than the female homologue. Thus, these studies have identified a new source of HY epitopes and provide additional information about the influence of posttranslational modifications of class I-associated peptides on T cell recognition.

Original languageEnglish
Pages (from-to)6360-4
Number of pages5
JournalJournal of Immunology
Issue number12
Publication statusPublished - 15 Dec 1999

Cite this